An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
WHO Guidelines for the Treatment of Chlamydia trachomatis.
Geneva: World Health Organization; 2016.
Top results in this bookTable of Contents
WHO Guidelines for the Treatment of Neisseria gonorrhoeae.
PDQ Cancer Information Summaries [Internet].
Bethesda (MD): National Cancer Institute (US); 2002-.
Food Allergy in Children and Young People: Diagnosis and Assessment of Food Allergy in Children and Young People in Primary Care and Community Settings.
London: National Institute for Health and Clinical Excellence (NICE); 2011 Feb. (NICE Clinical Guidelines, No. 116.)
Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access: Recommendations for a Public Health Approach: 2010 Revision.
Geneva: World Health Organization; 2010.
Brolucizumab (Beovu): CADTH Reimbursement Review: Therapeutic area: Diabetic macular edema [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Mar.
WHO guideline on school health services [Internet].
Geneva: World Health Organization; 2021.
Respiratory Tract Infections - Antibiotic Prescribing: Prescribing of Antibiotics for Self-Limiting Respiratory Tract Infections in Adults and Children in Primary Care.
London: National Institute for Health and Clinical Excellence (NICE); 2008 Jul. (NICE Clinical Guidelines, No. 69.)
Addendum to Jaundice in newborn babies under 28 days.
London: National Institute for Health and Care Excellence (NICE); 2016 May. (Clinical Guideline, No. 98.1.)
Pocket Book of Hospital Care for Children: Guidelines for the Management of Common Childhood Illnesses. 2nd edition.
Geneva: World Health Organization; 2013.
Surveillance Guidelines for Measles, Rubella and Congenital Rubella Syndrome in the WHO European Region.
Geneva: World Health Organization; 2012 Dec.
Response to Measles Outbreaks in Measles Mortality Reduction Settings: Immunization, Vaccines and Biologicals.
Geneva: World Health Organization; 2009 Mar.
Manual on Paediatric HIV Care and Treatment for District Hospitals: Addendum to the Pocket Book of Hospital Care of Children.
Geneva: World Health Organization; 2011.
Upadacitinib (Rinvoq): CADTH Reimbursement Recommendation: Indication: For the treatment of adults and adolescents 12 years of age and older with refractory moderate to severe atopic dermatitis who are not adequately controlled with a systemic treatment (e.g., steroid or biologic) or when use of those therapies is inadvisable. Upadacitinib can be used with or without topical corticosteroids [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Abrocitinib (Cibinqo): CADTH Reimbursement Recommendation: Indication: For the treatment of patients aged 12 years and older with refractory moderate to severe atopic dermatitis, including the relief of pruritus, who have had an inadequate response to other systemic drugs (e.g., steroid or biologic), or for whom these treatments are not advisable. Abrocitinib can be used with or without medicated topical therapies for atopic dermatitis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Sep.
Otitis media with effusion in under 12s.
London: National Institute for Health and Care Excellence (NICE); 2023 Aug 30. (NICE Guideline, No. 233.)
Prevention and Treatment of Mpox [Internet].
McLean JR, Zucker JE, Vail RM, et al.
Baltimore (MD): Johns Hopkins University; 2024 May.
CADTH Canadian Drug Expert Committee Recommendation: Cysteamine Ophthalmic Solution (Cystadrops — Recordati Rare Diseases Canada Inc.): Indication: Treatment of corneal cystine crystal deposits (CCCDs) in adults and children from 2 years of age with cystinosis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun.
CADTH Canadian Drug Expert Committee Recommendation: Dupilumab (Dupixent — Sanofi-Aventis Canada Inc.): Indication: Atopic dermatitis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Jul.
Faricimab (Vabysmo): CADTH Reimbursement Recommendation: Indication: For the treatment of diabetic macular edema [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Oct.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on